Pharmacological characterisation of strychnine and brucine analogues at glycine and α7 nicotinic acetylcholine receptors

European Journal of Pharmacology

Volumn 539, Issue 1-2, 2006, Pages 27-33

  Jensen, Anders A ^a   Gharagozloo, Parviz ^b   Birdsall, Nigel J M ^c   Zlotos, Darius P ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Brucine; Glycine receptor; Nicotinic acetylcholine receptor 7; Strychnine

Indexed keywords

BRUCINE; BUNGAROTOXIN RECEPTOR; GLYCINE RECEPTOR; ION CHANNEL; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; SEROTONIN 3 RECEPTOR; STRYCHNINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CHIMERA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; ELECTRONICS; EMBRYO; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

CELL LINE; DIMERIZATION; HUMANS; ION CHANNEL GATING; LIGANDS; MEMBRANE POTENTIALS; QUATERNARY AMMONIUM COMPOUNDS; RADIOLIGAND ASSAY; RECEPTORS, GLYCINE; RECEPTORS, NICOTINIC; RECEPTORS, SEROTONIN, 5-HT3; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; STRYCHNINE;

EID: 33744484568     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.04.010     Document Type: Article

References (28)

1. Albuquerque E.X., Pereira E.F., Braga M.F., Matsubayashi H., and Alkondon M. Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine. Toxicol. Lett. 28 (1998) 211-218
2. Baker E.R., Zwart R., Sher E., and Millar N.S. Pharmacological properties of the α9α10 nicotinic acetylcholine receptors revealed by heterologous expression of subunit chimeras. Mol. Pharmacol. 65 (2004) 453-460
3. Birdsall N.J., Farries T., Gharagozloo P., Kobayashi S., Lazareno S., and Sugimoto M. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies. Mol. Pharmacol. 55 (1999) 778-786
4. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van Der Oost J., Smit A.B., and Sixma T.K. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411 (2001) 269-276
5. Celie P.H., van Rossum-Fikkert S.E., van Dijk W.J., Brejc K., Smit A.B., and Sixma T.K. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41 (2004) 907-914
6. 3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 38 (1999) 679-690
7. Garcia-Colunga J., and Miledi R. Modulation of nicotinic acetylcholine receptors by strychnine. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4113-4118
8. Gharagozloo P., Lazareno S., Popham A., and Birdsall N.J. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors. J. Med. Chem. 42 (1999) 438-445
9. Han Y., Li P., and Slaughter M.M. Selective antagonism of rat inhibitory glycine receptor subunits. J. Physiol. 554 (2004) 649-658
10. Jensen A.A. Functional characterisation of human glycine receptors in a fluorescence-based high throughput screening assay. Eur. J. Pharmacol. 521 (2005) 39-42
11. Jensen A.A., and Kristiansen U. Functional characterisation of the human α1 glycine receptor in a fluorescence-based membrane-potential assay. Biochem. Pharmacol. 67 (2004) 1789-1799
12. Jensen A.A., Mikkelsen I., Frølund B., Bräuner-Osborne H., Falch E., and Krogsgaard-Larsen P. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 64 (2003) 865-875
13. Jensen A.A., Frølund B., Liljefors T., and Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications and therapeutic inspirations. J. Med. Chem. 48 (2005) 4705-4745
14. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev., Neurosci. 3 (2002) 102
15. A receptor chloride channel. Neurosci. Lett. 380 (2005) 340-345
16. 2+. J. Neurophysiol. 76 (1996) 227-241
17. Laube B., Maksay G., Schemm R., and Betz H. Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?. Trends Pharmacol. Sci. 23 (2002) 519-527
18. b from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation. Trends Pharmacol. Sci. 14 (1993) 237-239
19. Lazareno S., Gharagozloo P., Kuonen D., Popham A., and Birdsall N.J. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies. Mol. Pharmacol. 53 (1998) 573-589
20. Leff P., and Dougall I.G. Further concerns over Cheng-Prusoff analysis. Trends Pharmacol. Sci. 14 (1993) 110-112
21. Lewis T.M., Sivilotti L.G., Colquhoun D., Gardiner R.M., Schoepfer R., and Rees M. Properties of human glycine receptors containing the hyperekplexia mutation alpha1 (K276E), expressed in Xenopus oocytes. J. Physiol. 507 (1998) 25-40
22. Lynch J.W. Molecular structure and function of the glycine receptor chloride channel. Physiol. Rev. 84 (2004) 1051-1095
23. Mackerer C.R., Kochman R.L., Shen T.F., and Hershenson F.M. The binding of strychnine and strychnine analogs to synaptic membranes of rat brainstem and spinal cord. J. Pharmacol. Exp. Ther. 201 (1977) 326-331
24. Matsubayashi H., Alkondon M., Pereira E.F., Swanson K.L., and Albuquerque E.X. Strychnine: a potent competitive antagonist of α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 284 (1998) 904-913
25. Rajendra S., Lynch J.W., and Schofield P.R. The glycine receptor. Pharmacol. Ther. 73 (1997) 121-146
26. A receptor subtypes. Curr. Top. Med. Chem. 2 (2002) 795-816
27. Zlotos D.P., Buller S., Holzgrabe U., and Mohr K. Bisquaternary dimers of strychnine and brucine. A new class of potent enhancers of antagonist binding to muscarinic M2 receptors. Bioorg. Med. Chem. 11 (2003) 2627-2634
28. Zlotos D.P., Buller S., Stiefl N., Baumann K., and Mohr K. Probing the pharmacophore for allosteric ligands of muscarinic M2 receptors: SAR and QSAR studies in a series of bisquaternary salts of caracurine V and related ring systems. J. Med. Chem. 47 (2004) 3561-3571